Sky Century Investment (SKYI) Non-Current Assets (2024 - 2026)
Sky Century Investment's (SKYI) quarterly Non-Current Assets came in at $115499.0 in Q2 2026, up 5.6% year-on-year from $109375.0 in Q2 2025, and up 11.35% on a QoQ basis from $103726.0 in Q1 2026.
Sky Century Investment (SKYI) Non-Current Assets (2024 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 3 years of Non-Current Assets data on file, last reported at $115499.0 in Q2 2026.
- On a quarterly basis, Non-Current Assets rose 5.6% year-over-year to $115499.0 in Q2 2026; TTM through May 2026 was $438296.0, a 81.52% increase from a year earlier, with the FY2025 full-year figure at $109765.0, up 57.97% from the prior year.
- Non-Current Assets for Q2 2026 stood at $115499.0, up from $103726.0 in the prior quarter.
- Over the last five years, Non-Current Assets for SKYI reached as high as $115499.0 in Q2 2026 and fell as low as $62598.0 in Q1 2025.
- Historically, Non-Current Assets has averaged $97107.6 across 3 years, with a median of $109306.0 in 2025.
- On a YoY basis, Non-Current Assets climbed as much as 65.7% in 2026 and fell as far as 5.6% in 2026.
- Year by year, Non-Current Assets stood at $69484.0 in 2024, then surged by 57.31% to $109306.0 in 2025, then rose by 5.67% to $115499.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Assets figures were $115499.0 in Q2 2026, $103726.0 in Q1 2026, and $109306.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | 115,499.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 115,499.00 |
| Feb 28, 2026 | 103,726.00 |
| Nov 30, 2025 | 109,306.00 |
| Aug 31, 2025 | 109,765.00 |
| May 31, 2025 | 109,375.00 |
| Feb 28, 2025 | 62,598.00 |
| Aug 31, 2024 | 69,484.00 |